Approximately 4% of FRDA patients are compound heterozygotes, having a GAA repeat expansion on one allele and an inactivating or loss-of-function FXN gene mutation, such as a point mutation [2], [3] or a deletion/duplication [4]–[6] on the other allele. Here, FXN is linked to Friedreich ataxia.